The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...

U.S. federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.

The FDA approved Journavx, the first new pain medication in over 20 years ... Journavx will cost $15.50 per pill—significantly more than generic opioid medications, which often cost $1 or ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...